(R)-Carisbamate-d4, also known as labelled Carisbamate, is a compound that has been developed for the adjuvant treatment of partial onset epilepsy. It is a deuterated version of Carisbamate, which means it contains deuterium atoms instead of regular hydrogen atoms. This modification can enhance the compound's stability and solubility, making it more suitable for research and development purposes.
1287128-99-7
Post Buying Request-
-
Basic information
- Product Name: (R)-Carisbamate-d4
- Synonyms: (R)-Carisbamate-d4;(1R)-1-(2-Chlorophenyl-d4)-1,2-ethanediol 2-CarbaMate
- CAS NO:1287128-99-7
- Molecular Formula: C9H10ClNO3
- Molecular Weight: 215.6336
- EINECS: N/A
- Product Categories: Amines;Aromatics;Chiral Reagents;Intermediates & Fine Chemicals;Isotope Labelled Compounds;Pharmaceuticals
- Mol File: 1287128-99-7.mol
-
Chemical Properties
- Melting Point: N/A
- Boiling Point: N/A
- Flash Point: N/A
- Appearance: /
- Density: N/A
- Refractive Index: N/A
- Storage Temp.: N/A
- Solubility: N/A
- CAS DataBase Reference: (R)-Carisbamate-d4(CAS DataBase Reference)
- NIST Chemistry Reference: (R)-Carisbamate-d4(1287128-99-7)
- EPA Substance Registry System: (R)-Carisbamate-d4(1287128-99-7)
-
Safety Data
- Hazard Codes: N/A
- Statements: N/A
- Safety Statements: N/A
- WGK Germany:
- RTECS:
- HazardClass: N/A
- PackingGroup: N/A
- Hazardous Substances Data: 1287128-99-7(Hazardous Substances Data)
1287128-99-7 Suppliers
Recommended suppliers
1287128-99-7 Usage
Uses
Used in Pharmaceutical Industry:(R)-Carisbamate-d4 is used as an adjuvant treatment for partial onset epilepsy. It is effective in producing anticonvulsant effects in various seizure models, including primary generalized, complex partial, and absence-type seizures. Additionally, it exhibits neuroprotective and antiepileptogenic properties in rodent epilepsy models, making it a promising candidate for further research and development in the treatment of epilepsy.
Used in Research and Development:
(R)-Carisbamate-d4 is used as a research compound to study the mechanisms of action and potential therapeutic applications of Carisbamate. The deuterium labeling allows for better understanding of the compound's behavior in biological systems, as well as its interactions with other molecules and cellular targets. This information can be valuable in optimizing the drug's efficacy and safety profile, ultimately leading to improved treatment options for patients with epilepsy.
Check Digit Verification of cas no
The CAS Registry Mumber 1287128-99-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,8,7,1,2 and 8 respectively; the second part has 2 digits, 9 and 9 respectively.Calculate Digit Verification of CAS Registry Number 1287128-99:
(9*1)+(8*2)+(7*8)+(6*7)+(5*1)+(4*2)+(3*8)+(2*9)+(1*9)=187
187 % 10 = 7
So 1287128-99-7 is a valid CAS Registry Number.
1287128-99-7Upstream product
1287128-99-7Downstream Products
Post a RFQ
1
What can I do for you?
Get Best Price
Get Best Price for 1287128-99-7
(R)-Carisbamate-d4
